- Home
- AR vs SNN Comparison
AR vs SNN Comparison
Compare AR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AR
- SNN
- Stock Information
- Founded
- AR 2002
- SNN 1856
- Country
- AR United States
- SNN United Kingdom
- Employees
- AR N/A
- SNN N/A
- Industry
- AR Oil & Gas Production
- SNN Industrial Specialties
- Sector
- AR Energy
- SNN Health Care
- Exchange
- AR Nasdaq
- SNN Nasdaq
- Market Cap
- AR 12.7B
- SNN 12.7B
- IPO Year
- AR 2013
- SNN 1999
- Fundamental
- Price
- AR $37.75
- SNN $28.95
- Analyst Decision
- AR Buy
- SNN Hold
- Analyst Count
- AR 18
- SNN 3
- Target Price
- AR $41.88
- SNN $27.50
- AVG Volume (30 Days)
- AR 4.2M
- SNN 584.4K
- Earning Date
- AR 07-30-2025
- SNN 02-25-2025
- Dividend Yield
- AR N/A
- SNN 2.59%
- EPS Growth
- AR 2960.41
- SNN 56.15
- EPS
- AR 0.77
- SNN 0.47
- Revenue
- AR $4,609,825,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- AR $30.65
- SNN $6.87
- Revenue Next Year
- AR $5.86
- SNN $5.19
- P/E Ratio
- AR $48.33
- SNN $30.75
- Revenue Growth
- AR 6.79
- SNN 4.70
- 52 Week Low
- AR $24.53
- SNN $23.69
- 52 Week High
- AR $42.63
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- AR 53.79
- SNN 58.50
- Support Level
- AR $38.22
- SNN $28.55
- Resistance Level
- AR $40.42
- SNN $29.21
- Average True Range (ATR)
- AR 1.00
- SNN 0.38
- MACD
- AR -0.06
- SNN -0.02
- Stochastic Oscillator
- AR 31.92
- SNN 64.05
About AR Antero Resources Corporation
Antero Resources, based in Denver, engages in the exploration for and production of natural gas and natural gas liquids in the United States and Canada. At the end of 2024, the company reported proven reserves of 17.9 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,424 million cubic feet of equivalent a day in 2024 at a ratio of 35% liquids and 65% natural gas.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.